UC Berkeley, other institutions receive $20M for chemical innovation center

A research collaborative led by the University of California Berkeley has been awarded a $20 million five-year grant from the National Science Foundation to establish a chemical innovation research center.

Advertisement

The center aims to create new medicines and innovative treatment materials by pursuing the synthesis of sequence-defined chemical polymers. 

The research will be conducted by a team of chemists, biologists, engineers and data scientists in 14 laboratories at UC Berkeley, New Haven, Conn.-based Yale University, Stanford (Calif.) University, Ithaca, N.Y.-based Cornell University, Boston College and Chicago-based St. Jude Children’s Research Hospital.

More articles on health IT:
5 Epic program execs share tips on optimization during times of crisis
5 hospital-at-home initiatives from Adventist Health, Mayo Clinic & more
NIH boosts genomics initiatives with $75M funding

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.